These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4074660)

  • 1. Role of isomerization of initial complexes in the binding of inhibitors to dihydrofolate reductase.
    Blakley RL; Cocco L
    Biochemistry; 1985 Aug; 24(18):4772-7. PubMed ID: 4074660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of methotrexate to dihydrofolate reductase and its relation to protonation of the ligand.
    Blakley RL; Cocco L
    Biochemistry; 1985 Aug; 24(17):4704-9. PubMed ID: 3933559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
    Williams JW; Morrison JF; Duggleby RG
    Biochemistry; 1979 Jun; 18(12):2567-73. PubMed ID: 36135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aspartate 27 in the binding of methotrexate to dihydrofolate reductase from Escherichia coli.
    Appleman JR; Howell EE; Kraut J; Kühl M; Blakley RL
    J Biol Chem; 1988 Jul; 263(19):9187-98. PubMed ID: 3288632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of the formation and isomerization of methotrexate complexes of recombinant human dihydrofolate reductase.
    Appleman JR; Prendergast N; Delcamp TJ; Freisheim JH; Blakley RL
    J Biol Chem; 1988 Jul; 263(21):10304-13. PubMed ID: 3292526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of methotrexate binding to dihydrofolate reductase from Neisseria gonorrhoeae.
    Baccanari DP; Tansik RL
    Biochem Pharmacol; 1984 Jul; 33(13):2101-7. PubMed ID: 6430300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of substrate, coenzyme, and inhibitor binding to Escherichia coli dihydrofolate reductase.
    Cayley PJ; Dunn SM; King RW
    Biochemistry; 1981 Feb; 20(4):874-9. PubMed ID: 7011378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of dihydrofolate reductase. I. Inactivation of bacterial dihydrofolate reductase concomitant with modification of a methionine residue at the active site.
    Gleisner JM; Blakley RL
    J Biol Chem; 1975 Feb; 250(4):1580-7. PubMed ID: 1112818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical mechanism of the reaction catalyzed by dihydrofolate reductase from Streptococcus faecium: pH studies and chemical modification.
    Williams JW; Morrison JF
    Biochemistry; 1981 Oct; 20(21):6024-9. PubMed ID: 7306491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct experimental evidence for competitive inhibition of dihydrofolate reductase by methotrexate.
    Waltham MC; Holland JW; Robinson SC; Winzor DJ; Nixon PF
    Biochem Pharmacol; 1988 Feb; 37(3):535-9. PubMed ID: 3122764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon-13 nuclear magnetic resonance study of protonation of methotrexate and aminopterin bound to dihydrofolate reductase.
    Cocco L; Groff JP; Temple C; Montgomery JA; London RE; Matwiyoff NA; Blakley RL
    Biochemistry; 1981 Jul; 20(14):3972-8. PubMed ID: 7284303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of methotrexate metabolites with beef liver dihydrofolate reductase-I. Binary complex study.
    Chauvet M; Bourdeaux M; Briand C; Dell'Amico M; Gilli R; Diarra M
    Biochem Pharmacol; 1983 Mar; 32(6):1059-62. PubMed ID: 6838652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Stenotrophomonas maltophilia dihydrofolate reductase by methotrexate: a single slow-binding process.
    Navarro-Martínez MD; Cabezas-Herrera J; García-Cánovas F; Rodríguez-López JN
    J Enzyme Inhib Med Chem; 2007 Aug; 22(4):377-82. PubMed ID: 17847703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of phenylalanine 34 of human dihydrofolate reductase in substrate and inhibitor binding and in catalysis.
    Nakano T; Spencer HT; Appleman JR; Blakley RL
    Biochemistry; 1994 Aug; 33(33):9945-52. PubMed ID: 8061003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of bovine liver dihydrofolate reductase by tea catechins: origin of slow-binding inhibition and pH studies.
    Navarro-Perán E; Cabezas-Herrera J; Hiner AN; Sadunishvili T; García-Cánovas F; Rodríguez-López JN
    Biochemistry; 2005 May; 44(20):7512-25. PubMed ID: 15895994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic study of the influence of NADPH on the binding of methotrexate and its metabolites to a mammalian dihydrofolate reductase.
    Gilli RM; Sari JC; Sica LM; Briand CM
    Biochim Biophys Acta; 1988 Jan; 964(1):53-60. PubMed ID: 3334873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of arginine to lysine at position 70 of human dihydrofolate reductase: generation of a methotrexate-insensitive mutant enzyme.
    Thompson PD; Freisheim JH
    Biochemistry; 1991 Aug; 30(33):8124-30. PubMed ID: 1907850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.